跳至主要内容
临床试验/CTRI/2023/08/056952
CTRI/2023/08/056952尚未招募1/2 期

A Randomised Open Labelled Controlled Clinical Study to evaluate the efficacy of Dhanyamla Dhara in Diabetic Neuropathy

DR VAIDYANATH V.S1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年1月9日最近更新:

试验速览

阶段
1/2 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Assessment of the patients condition will be done based on

研究概览

简要总结

Dhanyamla is a medicine which can be used as multifaceted treatment. It is Jeevana (sustainer of life), Daha Nashana (mitigate burning sensation), Vata Kapha Nashaka (pacify vata & kapha), Trishna hara (mitigate thirst), Deepana (enhance digestion), Jarana (digestive), Sramahara (relieves fatigue) and  Klamahara (relieves exhaustion).

 Since the symptoms of Diabetic Peripheral Neuropathy such as pain, burning sensation, numbness and tingling sensation can be correlated to the involvement of vitiated Vata and Kapha, Dhanyamla, having properties of Vata Kapha nashaka, Dahahara, Trisnahara, etc can be used for the treatment of Diabetic Peripheral Neuropathy. Hence*, Sarvanga dhara* by Dhanyamla in Diabetic Peripheral Neuropathy is choosen for this study.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
30.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Metabolically stable diabetic subjects with symptomatic Diabetic Peripheral Neuropathy.
  • 2.Subjects of all gender between the age group of 30-65 years.
  • 3.Subjects fulfilling the diagnostic criteria.
  • 4.Subjects whose HbA1C is between 6.5 to 10%.

排除标准

  • 1.Subjects where HbA1C >10% and <6.5%.
  • 2.Subjects suffering from Type-1 Diabetes or Gestational Diabetes.
  • 3.Pregnant and lactating women.
  • 4.Subjects suffering from infectious diseases and non-healing ulcer/ ulcers of foot.
  • 5.Any systemic illness that can interfere with the course of treatment.

结局指标

主要结局

Assessment of the patients condition will be done based on

时间窗: Before intervention 0th day | After intervention 7th day | Follow up 14th day

1.Changes in Michigan Neuropathy Screening Instrument (MNSI) Questionnaire score

时间窗: Before intervention 0th day | After intervention 7th day | Follow up 14th day

2.Changes in Toronto Neuropathy Clinical Scale (TCNS) Score

时间窗: Before intervention 0th day | After intervention 7th day | Follow up 14th day

3.Changes in Visual Analog Scale (VAS)

时间窗: Before intervention 0th day | After intervention 7th day | Follow up 14th day

次要结局

  • 1. Changes in FBS value(2. Changes in PPBS value)

研究者

发起方
DR VAIDYANATH V.S
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验